According to our results, CD147 was highly expressed in HER2-positive breast cancer tissues, verifying that CD147 and HER2 are frequently simultaneously expressed in HER2-positive breast cancer tissues in vivo. This evidence concerns the gene ERBB2 and breast cancer.